Tasneem Zaihra

Tasneem Zaihra

Auto-generated profile, based on publicly available information

Tasneem Zaihra

Lahey Hospital & Medical Center, Burlington, MA, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SASara Ahmed
Sara Ahmed
PEPierre Ernst
Pierre Ernst
SBSusan J Bartlett
Susan J Bartlett
MVMarie-France Valois
Marie-France Valois
TZTasneem Zaihra
Tasneem Zaihra
RTRobyn Tamblyn
Robyn Tamblyn
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

18 April 2015 in Respiratory Research
Verified
Journal Article
Open access
PDF file
LPLancelot M Pinto
Lancelot M Pinto
MAMajed Alghamdi
Majed Alghamdi
ABAndrea Benedetti
Andrea Benedetti
TZTasneem Zaihra
Tasneem Zaihra
TLTara Landry
Tara Landry
JBJean Bourbeau
Jean Bourbeau
The traditional classification of COPD, which relies solely on spirometry, fails to account for the complexity and heterogeneity of the disease. Phenotyping is a method that attempts to derive a single or combination of disease attributes that are associated with clinically meaningful outcomes. Deriving phenotypes entails the use of cluster analyses, and helps individualize patient management by identifying groups of individuals with similar characteristics. We aimed to systematically review the literature for studies that had derived such phenotypes using unsupervised methods. Two independent reviewers systematically searched multiple databases for studies that performed validated statistical analyses, free of definitive pre-determined hypotheses, to derive phenotypes among patients with COPD. Data were extracted independently. 9156 citations were retrieved, of which, 8 studies were included. The number of subjects ranged from 213 to 1543. Most studies appeared to be biased: patients were more likely males, with severe disease, and recruited in tertiary care settings. Statistical methods used to derive phenotypes varied by study. The number of phenotypes identified ranged from 2 to 5. Two phenotypes, with poor longitudinal health outcomes, were common across multiple studies: young patients with severe respiratory disease, few cardiovascular co-morbidities, poor nutritional status and poor health status, and a phenotype of older patients with moderate respiratory disease, obesity, cardiovascular and metabolic co-morbidities. The recognition that two phenotypes of COPD were often reported may have clinical implications for altering the course of the disease. This review also provided important information on limitations of phenotype studies in COPD and the need for improvement in future studies.

23 May 2016 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
CWC. J. Walsh
C. J. Walsh
TZT. Zaihra
T. Zaihra
ABA. Benedetti
A. Benedetti
CFC. Fugère
C. Fugère
ROR. Olivenstein
R. Olivenstein
JMJ. G. Martin
J. G. Martin

10 May 2016 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
TZT. Zaihra
T. Zaihra
CWC. J. Walsh
C. J. Walsh
SAS. Ahmed
S. Ahmed
CFC. Fugère
C. Fugère
QHQ. A. Hamid
Q. A. Hamid
ABA. Benedetti
A. Benedetti
Although the heterogeneous nature of asthma has prompted asthma phenotyping with physiological or biomarker data, these studies have been mostly cross-sectional. Longitudinal studies that assess the stability of phenotypes based on a combination of physiological, clinical and biomarker data are currently lacking. Our objective was to assess the longitudinal stability of clusters derived from repeated measures of airway and physiological data over a 1-year period in moderate and severe asthmatics. A total of 125 subjects, 48 with moderate asthma (MA) and 77 with severe asthma (SA) were evaluated every 3 months and monthly, respectively, over a 1-year period. At each 3-month time point, subjects were grouped into 4 asthma clusters (A, B, C, D) based on a combination of clinical (duration of asthma), physiological (FEV1 and BMI) and biomarker (sputum eosinophil count) variables, using k-means clustering. Majority of subjects in clusters A and C had severe asthma (93 % of subjects in cluster A and 79.5 % of subjects in cluster C at baseline). Overall, a total of 59 subjects (47 %) had stable cluster membership, remaining in clusters with the same subjects at each evaluation time. Cluster A was the least stable (21 % stability) and cluster B was the most stable cluster (71 % stability). Cluster stability was not influenced by changes in the dosage of inhaled corticosteroids. Asthma phenotyping based on clinical, physiologic and biomarker data identified clusters with significant differences in longitudinal stability over a 1-year period. This finding indicates that the majority of patients within stable clusters can be phenotyped with reasonable accuracy after a single measurement of lung function and sputum eosinophilia, while patients in unstable clusters will require more frequent evaluation of these variables to be properly characterized.

14 April 2008 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
SPSudhir Paul
Sudhir Paul
TZTasneem Zaihra
Tasneem Zaihra

1 June 2015 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
TZTasneem Zaihra
Tasneem Zaihra
PEPierre Ernst
Pierre Ernst
RTRobyn Tamblyn
Robyn Tamblyn
SASara Ahmed
Sara Ahmed